Loading
journalsJournal
Journal of cachexia, sarcopenia and muscle
The open access journal for wasting syndromes: the muscle and weight loss that accompanies advanced cancer and other chronic diseases. Read by oncologists, geriatricians, nutrition scientists and muscle biologists.
Also called: J Cachexia Sarcopenia MuscleJCSM
Overview
The Journal of Cachexia, Sarcopenia and Muscle is published by Wiley on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders, which describes it as a peer-reviewed international journal dedicated to publishing both research and clinical materials related to cachexia and sarcopenia from all fields of the life sciences. NLM catalogues it from 2010 as a quarterly, first published in Germany, indexed for MEDLINE under Cachexia, Muscles and Sarcopenia. The Directory of Open Access Journals lists it as fully open access since 2010 under a CC BY licence, with anonymous peer review and an article processing charge.
Publisher
Wiley · Society on Sarcopenia, Cachexia and Wasting Disorders
Scope
cancer cachexia and muscle wasting
Access model
open access
Founded
2010
ISSN
2190-6009
Similar pages
- TechnologyHydrazine sulfate
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TechnologyFish oil (EPA) for cancer weight loss
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TrialROMANA 1 and ROMANA 2
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TrialPonsegromab phase 2 in cancer cachexia
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TechnologyMuscle and strength after treatment: sarcopenia, cachexia and what rebuilds
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TechnologyResistance training and protein for cachexia and sarcopenia
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TechnologyCachexia pharmacotherapy: GDF-15 blockade, anamorelin, olanzapine
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.